Anika Ackerman, MD
Urology · Morristown, NJNPI 1326307877
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $20,100 of the $24,694 with a category attached, or 81.4%. Johnson & Johnson accounts for 81.5% of it on its own, with 42 other manufacturers making up the rest. 2025 is the largest year on record at $21,256, more than ten times the $207 reported in 2019. Among urology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 155 payments — averaging $159.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$20K
- Medtronic$513
- AbbVie$439
- Calyxo, Inc.$329
- Astellas Pharma US Inc$281
- Sumitomo Pharma America, Inc.$248
- plus $3K from 37 others
What the payments were for
- Consulting fees$20,10081%
- Food & beverage$4,46618%
- Education$1291%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CVAC Aspiration System$295
- KYPHON EXPRESS II KYPHOPAK TRAY$170
- Desara$142
- ANKTIVA$136
- INTERSTIM$136
- BOTOX$130
- PureWick Female External Catheter$130
- ADSTILADRIN$125
- Veozah$120
How this compares
$24,694 in reported general payments places this provider in the 90th percentile of 401 urology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 504 | $336,566 |
| GemtesaVibegron | 172 | $128,673 |
| Mirabegron ErMirabegron | 36 | $21,531 |
| Estradiol | 240 | $16,731 |
| Methenamine Hippurate | 112 | $9,888 |
| Tamsulosin Hcl | 338 | $5,733 |
| Potassium Citrate ErPotassium Citrate | 39 | $5,417 |
| Desmopressin Acetate | 38 | $5,280 |
| YuvafemEstradiol | 23 | $3,891 |
| Finasteride | 179 | $2,536 |
| Solifenacin Succinate | 78 | $1,698 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 96 | $1,535 |
| Dutasteride | 18 | $1,518 |
| Trimethoprim | 17 | $1,409 |
| NitrofurantoinNitrofurantoin Macrocrystal | 33 | $1,376 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $281 | $336,566504 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $248 | $128,673172 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 401 urology providers in New Jersey.
Other urology in Morristown
- David TaylorMorristown$68K
- David ChaikinMorristown$51K
- Benjamin TaylorMorristown$37K
- Ayal KaynanMorristown$13K
- Lee PresslerMorristown$12K
- Joseph SteinbergMorristown$9K
- Michael StifelmanHackensack$1.4M
- Gordon BrownCherry Hill$1.3M
- Thomas MuellerLinwood$1.1M
- David SussmanLinwood$802K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.